GSK3 phosphorylation of certain proteins enhances their proteasomal degradation, and it is possible that this is the case for RARα as treatment of myeloid leukemia cells with GSK-3 inhibitors led to enhanced expression of RARα [86]. Here, RARA is linked to myeloid leukemia.